Workflow
The Cooper Companies(COO)
icon
Search documents
LH vs. COO: Which Stock Should Value Investors Buy Now?
Zacks Investment Research· 2024-04-17 16:41
Investors with an interest in Medical - Dental Supplies stocks have likely encountered both Labcorp (LH) and The Cooper Companies (COO) . But which of these two stocks presents investors with the better value opportunity right now? Let's take a closer look.We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, ...
The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Seeking Alpha· 2024-03-22 03:00
BlackJack3DOverview I previously rated a hold rating for The Cooper Companies (NASDAQ:COO), as I thought the valuation was too high back then, in July 2023. I believe my call was right, as the stock saw a sharp reversion back to its historical trading multiple of 19-22x forward PE, which led to a sharp reversion in share price from ~$100 to $75 in just 3 months. As COO ended FY23, I thought to give an update on the business and my outlook. My recommendation for COO is a buy rating with an expected retur ...
LH or COO: Which Is the Better Value Stock Right Now?
Zacks Investment Research· 2024-03-12 16:41
Investors interested in Medical - Dental Supplies stocks are likely familiar with Labcorp (LH) and The Cooper Companies (COO) . But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on ear ...
Reasons to Add The Cooper Companies (COO) to Your Portfolio Now
Zacks Investment Research· 2024-03-11 13:31
The Cooper Companies, Inc. (COO) is well-poised for growth, backed by strong prospects in its CooperVision (CVI) and CooperSurgical (CSI) business segments. Acquisitions boost the company’s portfolio and buoy optimism. However, unfavorable currency movements and rising costs continue to hurt revenues and margins, respectively.Shares of this currently Zacks Rank #2 (Buy) company have risen 15.5% in the past six months compared with the industry's 3.8% growth. The S&P 500 Index has gained 13.4% in the same ti ...
The Cooper Companies(COO) - 2024 Q1 - Earnings Call Transcript
2024-03-02 02:59
The Cooper Companies, Inc. (NASDAQ:COO) Q1 2024 Earnings Conference Call February 29, 2024 5:00 PM ET Company Participants Kim Duncan - VP of IR & Risk Management Albert White - President and CEO Brian Andrews - CFO & Treasurer Conference Call Participants Craig Bijou - Bank of America Lawrence Biegelsen - Wells Fargo Jeffrey Johnson - Baird Joanne Wuensch - Citi Group Anthony Petrone - Mizuho Group Jason Bednar - Piper Sandler Patrick Wood - Morgan Stanley Robbie Marcus - JPMorgan Christopher Pasquale - Ne ...
Cooper Companies (COO) Q1 Earnings Top, '24 Outlook Raised
Zacks Investment Research· 2024-03-01 13:11
The Cooper Companies, Inc. (COO) reported first-quarter fiscal 2024 adjusted earnings per share (EPS) of 85 cents, which beat the Zacks Consensus Estimate of 79 cents by 7.6%. The bottom line rose 18% on a year-over-year basis.GAAP EPS in the quarter declined 5% from the year-ago period’s level to 41 cents, primarily due to rising expenses.Revenue DetailsRevenues totaled $931.6 million, which outpaced the Zacks Consensus Estimate by 1.8%. The top line improved 9% on a year-over-year basis and 8% at constant ...
The Cooper Companies (COO) Reports Q1 Earnings: What Key Metrics Have to Say
Zacks Investment Research· 2024-03-01 00:01
For the quarter ended January 2024, The Cooper Companies (COO) reported revenue of $931.6 million, up 8.5% over the same period last year. EPS came in at $0.85, compared to $0.73 in the year-ago quarter.The reported revenue compares to the Zacks Consensus Estimate of $915.17 million, representing a surprise of +1.80%. The company delivered an EPS surprise of +7.59%, with the consensus EPS estimate being $0.79.While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wa ...
The Cooper Companies (COO) Q1 Earnings and Revenues Top Estimates
Zacks Investment Research· 2024-02-29 23:31
The Cooper Companies (COO) came out with quarterly earnings of $0.85 per share, beating the Zacks Consensus Estimate of $0.79 per share. This compares to earnings of $0.73 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.59%. A quarter ago, it was expected that this surgical and contact lens products maker would post earnings of $0.87 per share when it actually produced earnings of $0.87, delivering no surprise.Over the last ...
The Cooper Companies(COO) - 2024 Q1 - Quarterly Report
2024-02-29 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _____________________________________________________________ Title of each class Trading Symbol Name of each exchange on which registered Common Stock, $.10 par value Nasdaq Global Select Market Emerging growth company ☐ ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to ...
The Cooper Companies(COO) - 2024 Q1 - Quarterly Results
2024-02-28 16:00
PRESS RELEASE CooperCompanies Announces First Quarter 2024 Results San Ramon, Calif., February 29, 2024 — CooperCompanies (Nasdaq: COO), a leading global medical device company, today announced financial results for its fiscal first quarter ended January 31, 2024. Commenting on the results, Al White, Cooper's President and CEO said, "We're off to an outstanding start this fiscal year. We delivered record quarterly revenues in Q1 with contact lenses growing solidly and fertility posting its thirteenth consec ...